Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Current status and future trends of the global burden of MASLD
Metabolic dysfunction-associated steatotic liver disease (MASLD) has emerged as the most
common chronic liver disease globally, affecting more than a third of the world's adult …
common chronic liver disease globally, affecting more than a third of the world's adult …
Recompensation in cirrhosis: unravelling the evolving natural history of nonalcoholic fatty liver disease
Recompensation has gained increasing attention in the field of cirrhosis, particularly in
chronic liver disease with a definite aetiology. The current global prevalence of obesity and …
chronic liver disease with a definite aetiology. The current global prevalence of obesity and …
[HTML][HTML] Steatotic liver disease, MASLD and risk of chronic kidney disease
With the rising tide of fatty liver disease related to metabolic dysfunction worldwide, the
association of this common liver disease with chronic kidney disease (CKD) has become …
association of this common liver disease with chronic kidney disease (CKD) has become …
Partitioned polygenic risk scores identify distinct types of metabolic dysfunction-associated steatotic liver disease
Metabolic dysfunction-associated steatotic liver disease (MASLD) is characterized by an
excess of lipids, mainly triglycerides, in the liver and components of the metabolic syndrome …
excess of lipids, mainly triglycerides, in the liver and components of the metabolic syndrome …
An international multidisciplinary consensus on pediatric metabolic dysfunction-associated fatty liver disease
Background Non-alcoholic fatty liver disease (NAFLD) is highly prevalent in children and
adolescents, particularly those with obesity. NAFLD is considered a hepatic manifestation of …
adolescents, particularly those with obesity. NAFLD is considered a hepatic manifestation of …
Hepatocytic ballooning in non‐alcoholic steatohepatitis: Dilemmas and future directions
Hepatocytic ballooning is a key histological feature in the diagnosis of non‐alcoholic
steatohepatitis (NASH) and is an essential component of the two most widely used …
steatohepatitis (NASH) and is an essential component of the two most widely used …
MAFLD as part of systemic metabolic dysregulation
Nonalcoholic fatty liver disease (NAFLD) is one of the most common chronic liver diseases
worldwide. In recent years, a new terminology and definition of metabolic dysfunction …
worldwide. In recent years, a new terminology and definition of metabolic dysfunction …
Severity and Remission of Metabolic Dysfunction–Associated Fatty/Steatotic Liver Disease With Chronic Kidney Disease Occurrence
J Gao, Y Li, Y Zhang, X Zhan, X Tian, J Li… - Journal of the …, 2024 - ahajournals.org
Background The association of the severity of hepatic steatosis in metabolic dysfunction–
associated fatty liver disease (MAFLD)/metabolic dysfunction–associated steatotic liver …
associated fatty liver disease (MAFLD)/metabolic dysfunction–associated steatotic liver …
Serum bile acid profiles are associated with heart failure with preserved ejection fraction in patients with metabolic dysfunction‐associated fatty liver disease: an …
Aim To analyse the association between serum bile acid (BA) profile and heart failure (HF)
with preserved ejection fraction (HFpEF) in patients with metabolic dysfunction‐associated …
with preserved ejection fraction (HFpEF) in patients with metabolic dysfunction‐associated …
[HTML][HTML] MAFLD criteria are better than MASLD criteria at predicting the risk of chronic kidney disease
Z Pan, M Derbala, K AlNaamani, H Ghazinian… - Annals of …, 2024 - Elsevier
Abstract Introduction and Objectives Fatty liver disease is a multisystem disease. Metabolic
dysfunction-associated fatty liver disease (MAFLD) is a more accurate indicator of chronic …
dysfunction-associated fatty liver disease (MAFLD) is a more accurate indicator of chronic …